News
Medical Device Network on MSN1d
ASCO25: AI test shown to aid in prostate cancer treatment planningResearchers used ArteraAI to identify 25% of prostate cancer patients in a large trial cohort for whom abiraterone halved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback